• 11/11/2024

FDA Looking Into CAR T Therapies on Cancer Risk

Wall Street Journal

The U.S. Food and Drug Administration is investigating certain CAR T cancer therapies based on reports that they might cause a type of white blood cell to become cancerous in patients who received the treatment.

https://www.wsj.com/articles/fda-looking-into-all-approved-car-t-therapies-on-risk-of-cancer-in-white-blood-cells-88675d1b